PMHNP-BC Certification Exam Actual Exam 2026/2027 –
Complete Reported Q&A with Detailed Rationales | 100%
Verified | Pass Guaranteed – A+ Graded
Section A: Neurobiology, Pathophysiology, & Psychopharmacology (18
Questions)
Q1: A 28-year-old patient with schizophrenia is prescribed haloperidol. The PMHNP
explains that the medication's therapeutic effect is primarily mediated through
antagonism of which neurotransmitter receptor?
A. Serotonin 5-HT2A receptors
B. Dopamine D2 receptors [CORRECT]
C. Norepinephrine alpha-1 receptors
D. GABA-A receptors
Correct Answer: B
Rationale: Typical antipsychotics like haloperidol exert their antipsychotic effect
primarily through D2 receptor antagonism in the mesolimbic pathway. Atypical
antipsychotics (A) also antagonize 5-HT2A; alpha-1 blockade (C) causes orthostasis;
GABA-A (D) is the benzodiazepine target. ANCC PMHNP: D2 antagonism is the primary
mechanism for typical antipsychotics.
Q2: A patient on fluoxetine begins taking tramadol for back pain and develops agitation,
hyperthermia, diaphoresis, tremor, and diarrhea. The PMHNP recognizes these findings
as:
A. Neuroleptic malignant syndrome
,B. Serotonin syndrome [CORRECT]
C. Malignant hyperthermia
D. Acute dystonia
Correct Answer: B
Rationale: Serotonin syndrome presents with the triad of mental status changes
(agitation), autonomic instability (hyperthermia, diaphoresis), and neuromuscular
abnormalities (tremor, diarrhea). Fluoxetine (SSRI) plus tramadol (serotonin reuptake
inhibitor) precipitates this. NMS (A) has rigidity and normal pupils; malignant
hyperthermia (C) follows anesthesia; dystonia (D) presents with muscle spasms.
DSM-5-TR/ANCC: Serotonin syndrome requires serotonergic drug interaction.
Q3: A patient with bipolar disorder is started on lithium carbonate. The PMHNP should
instruct the patient to maintain adequate hydration and avoid which medication class
due to risk of lithium toxicity?
A. Proton pump inhibitors
B. NSAIDs and thiazide diuretics [CORRECT]
C. Beta-blockers
D. H2 receptor antagonists
Correct Answer: B
Rationale: NSAIDs and thiazide diuretics reduce lithium clearance, increasing serum
levels and toxicity risk. PPIs (A), beta-blockers (C), and H2 blockers (D) do not
significantly affect lithium levels. ANCC PMHNP: Lithium is renally cleared; drugs
affecting renal function or sodium balance require monitoring.
Q4: A patient on clozapine develops fever, sore throat, and malaise. Laboratory studies
reveal an absolute neutrophil count (ANC) of 850/mm³. The PMHNP should:
,A. Continue clozapine and increase the dose
B. Immediately discontinue clozapine and do not rechallenge [CORRECT]
C. Add granulocyte colony-stimulating factor and continue clozapine
D. Switch to olanzapine without monitoring
Correct Answer: B
Rationale: ANC <1000/mm³ indicates severe neutropenia; clozapine must be
immediately discontinued and not rechallenge per REMS requirements. Continuing (A)
is fatal; G-CSF (C) is not a substitute for discontinuation; switching without monitoring
(D) ignores the need for ongoing ANC surveillance. ANCC PMHNP: Clozapine REMS
requires weekly then biweekly ANC monitoring.
Q5: A patient with treatment-resistant depression is started on phenelzine. The PMHNP
provides dietary counseling emphasizing avoidance of which substance?
A. Grapefruit juice
B. Tyramine-containing foods [CORRECT]
C. Dairy products
D. Green leafy vegetables
Correct Answer: B
Rationale: MAOIs like phenelzine inhibit MAO-A, preventing tyramine breakdown; dietary
tyramine can precipitate hypertensive crisis. Grapefruit (A) affects CYP3A4; dairy (C)
and vegetables (D) are not contraindicated. ANCC PMHNP: Tyramine restriction is
essential for all non-transdermal MAOIs.
Q6: A patient on bupropion XL 300 mg daily reports insomnia and anxiety. The PMHNP
should recommend:
A. Adding a benzodiazepine for sleep
, B. Moving the dose to the morning and assessing for seizure risk factors [CORRECT]
C. Discontinuing immediately due to mania induction
D. Increasing the dose to 450 mg to reduce side effects
Correct Answer: B
Rationale: Bupropion's activating effects (insomnia, anxiety) are managed by morning
dosing; seizure risk requires assessment. Benzodiazepines (A) are not first-line for
medication-induced insomnia; mania (C) is not indicated; increasing dose (D) worsens
side effects. ANCC PMHNP: Bupropion is contraindicated in seizure disorders and
eating disorders.
Q7: A patient with generalized anxiety disorder is started on buspirone. The PMHNP
explains that the onset of therapeutic effect is typically:
A. Within 30 minutes of the first dose
B. Delayed 2-4 weeks [CORRECT]
C. Immediate within 1 hour
D. Not expected for 6 months
Correct Answer: B
Rationale: Buspirone is a 5-HT1A partial agonist with delayed onset (2-4 weeks), similar
to antidepressants. It is not an as-needed anxiolytic like benzodiazepines. ANCC
PMHNP: Buspirone lacks immediate anxiolytic effect and is not effective for panic
disorder.
Q8: A patient with ADHD is started on methylphenidate. The PMHNP should monitor for
which cardiovascular effect?
A. Bradycardia and hypotension
B. Increased heart rate and blood pressure [CORRECT]
Complete Reported Q&A with Detailed Rationales | 100%
Verified | Pass Guaranteed – A+ Graded
Section A: Neurobiology, Pathophysiology, & Psychopharmacology (18
Questions)
Q1: A 28-year-old patient with schizophrenia is prescribed haloperidol. The PMHNP
explains that the medication's therapeutic effect is primarily mediated through
antagonism of which neurotransmitter receptor?
A. Serotonin 5-HT2A receptors
B. Dopamine D2 receptors [CORRECT]
C. Norepinephrine alpha-1 receptors
D. GABA-A receptors
Correct Answer: B
Rationale: Typical antipsychotics like haloperidol exert their antipsychotic effect
primarily through D2 receptor antagonism in the mesolimbic pathway. Atypical
antipsychotics (A) also antagonize 5-HT2A; alpha-1 blockade (C) causes orthostasis;
GABA-A (D) is the benzodiazepine target. ANCC PMHNP: D2 antagonism is the primary
mechanism for typical antipsychotics.
Q2: A patient on fluoxetine begins taking tramadol for back pain and develops agitation,
hyperthermia, diaphoresis, tremor, and diarrhea. The PMHNP recognizes these findings
as:
A. Neuroleptic malignant syndrome
,B. Serotonin syndrome [CORRECT]
C. Malignant hyperthermia
D. Acute dystonia
Correct Answer: B
Rationale: Serotonin syndrome presents with the triad of mental status changes
(agitation), autonomic instability (hyperthermia, diaphoresis), and neuromuscular
abnormalities (tremor, diarrhea). Fluoxetine (SSRI) plus tramadol (serotonin reuptake
inhibitor) precipitates this. NMS (A) has rigidity and normal pupils; malignant
hyperthermia (C) follows anesthesia; dystonia (D) presents with muscle spasms.
DSM-5-TR/ANCC: Serotonin syndrome requires serotonergic drug interaction.
Q3: A patient with bipolar disorder is started on lithium carbonate. The PMHNP should
instruct the patient to maintain adequate hydration and avoid which medication class
due to risk of lithium toxicity?
A. Proton pump inhibitors
B. NSAIDs and thiazide diuretics [CORRECT]
C. Beta-blockers
D. H2 receptor antagonists
Correct Answer: B
Rationale: NSAIDs and thiazide diuretics reduce lithium clearance, increasing serum
levels and toxicity risk. PPIs (A), beta-blockers (C), and H2 blockers (D) do not
significantly affect lithium levels. ANCC PMHNP: Lithium is renally cleared; drugs
affecting renal function or sodium balance require monitoring.
Q4: A patient on clozapine develops fever, sore throat, and malaise. Laboratory studies
reveal an absolute neutrophil count (ANC) of 850/mm³. The PMHNP should:
,A. Continue clozapine and increase the dose
B. Immediately discontinue clozapine and do not rechallenge [CORRECT]
C. Add granulocyte colony-stimulating factor and continue clozapine
D. Switch to olanzapine without monitoring
Correct Answer: B
Rationale: ANC <1000/mm³ indicates severe neutropenia; clozapine must be
immediately discontinued and not rechallenge per REMS requirements. Continuing (A)
is fatal; G-CSF (C) is not a substitute for discontinuation; switching without monitoring
(D) ignores the need for ongoing ANC surveillance. ANCC PMHNP: Clozapine REMS
requires weekly then biweekly ANC monitoring.
Q5: A patient with treatment-resistant depression is started on phenelzine. The PMHNP
provides dietary counseling emphasizing avoidance of which substance?
A. Grapefruit juice
B. Tyramine-containing foods [CORRECT]
C. Dairy products
D. Green leafy vegetables
Correct Answer: B
Rationale: MAOIs like phenelzine inhibit MAO-A, preventing tyramine breakdown; dietary
tyramine can precipitate hypertensive crisis. Grapefruit (A) affects CYP3A4; dairy (C)
and vegetables (D) are not contraindicated. ANCC PMHNP: Tyramine restriction is
essential for all non-transdermal MAOIs.
Q6: A patient on bupropion XL 300 mg daily reports insomnia and anxiety. The PMHNP
should recommend:
A. Adding a benzodiazepine for sleep
, B. Moving the dose to the morning and assessing for seizure risk factors [CORRECT]
C. Discontinuing immediately due to mania induction
D. Increasing the dose to 450 mg to reduce side effects
Correct Answer: B
Rationale: Bupropion's activating effects (insomnia, anxiety) are managed by morning
dosing; seizure risk requires assessment. Benzodiazepines (A) are not first-line for
medication-induced insomnia; mania (C) is not indicated; increasing dose (D) worsens
side effects. ANCC PMHNP: Bupropion is contraindicated in seizure disorders and
eating disorders.
Q7: A patient with generalized anxiety disorder is started on buspirone. The PMHNP
explains that the onset of therapeutic effect is typically:
A. Within 30 minutes of the first dose
B. Delayed 2-4 weeks [CORRECT]
C. Immediate within 1 hour
D. Not expected for 6 months
Correct Answer: B
Rationale: Buspirone is a 5-HT1A partial agonist with delayed onset (2-4 weeks), similar
to antidepressants. It is not an as-needed anxiolytic like benzodiazepines. ANCC
PMHNP: Buspirone lacks immediate anxiolytic effect and is not effective for panic
disorder.
Q8: A patient with ADHD is started on methylphenidate. The PMHNP should monitor for
which cardiovascular effect?
A. Bradycardia and hypotension
B. Increased heart rate and blood pressure [CORRECT]
